Synagis Side Effects
Generic name: palivizumab
Medically reviewed by Drugs.com. Last updated on Apr 20, 2025.
Note: This document provides detailed information about Synagis.
Applies to palivizumab: intramuscular solution Side Effects associated with palivizumab. Some dosage forms listed on this page may not apply specifically to the brand name Synagis.
Applies to palivizumab: intramuscular solution.
Precautions
It is very important that your doctor check your child's progress at regular visits. This will allow your child's doctor to see if the medicine is working properly and to decide if your child should continue to use it.
This medicine may cause serious types of allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if your child has a rash, itching, hoarseness, lightheadedness, dizziness, or fainting, trouble breathing, trouble swallowing, or any swelling of the hands, face, or mouth after receiving the medicine.
If your child has certain types of heart disease and needs to have a corrective surgery, your doctor may need to give your child an additional shot of this medicine soon after surgery.
Make sure any doctor or dentist who treats your child knows that he or she is using this medicine. This medicine may affect the results of certain medical tests.
Serious side effects of Synagis
Along with its needed effects, palivizumab (the active ingredient contained in Synagis) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking palivizumab:
More common side effects
- bluish color of the fingernails, lips, skin, palms, or nail beds
- blurred vision
- confusion
- cough
- difficulty with breathing
- difficulty with swallowing
- dizziness
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- fast heartbeat
- fever
- hives or welts
- irregular, fast or slow, or shallow breathing
- itching
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- loss of strength or energy
- muscle pain or weakness
- redness of the skin
- shortness of breath
- skin rash
- sweating
- tightness in the chest
- unresponsiveness
- unusual tiredness or weakness
- wheezing
Incidence not known
- black, tarry stools
- bleeding gums
- blood in the urine or stools
- pinpoint red spots on the skin
- unusual bleeding or bruising
Other side effects of Synagis
Some side effects of palivizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
- bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
For healthcare professionals
Applies to palivizumab: intramuscular powder for injection, intramuscular solution.
General adverse events
The most serious adverse reactions are anaphylaxis and other acute hypersensitivity reactions.[Ref]
Gastrointestinal
Hypersensitivity
- Frequency not reported: Anaphylaxis, anaphylactic shock (sometimes fatal)
- Postmarketing reports: Angioedema[Ref]
Local
- Common (1% to 10%): Injection site reactions[Ref]
Other
- Very common (10% or more): Pyrexia[Ref]
Dermatologic
- Very common (10% or more): Rash
- Uncommon (0.1% to 1%): Urticaria
- Frequency not reported: Pruritus[Ref]
Cardiovascular
- Frequency not reported: Arrhythmia (during studies of congenital heart disease patients)[Ref]
Hematologic
- Uncommon (0.1% to 1%): Thrombocytopenia (mild), eosinophilia (mild)
- Postmarketing reports: Severe thrombocytopenia (platelet count less than 50,000/microliter)[Ref]
Nervous system
- Uncommon (0.1% to 1%): Convulsions[Ref]
Respiratory
- Frequency not reported: Cyanosis during studies of congenital heart disease patients
- Postmarketing reports: Dyspnea, asthma, bronchospasm[Ref]
See also:
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Beyfortus
Beyfortus is used to protect babies under 1 year of age from serious RSV lung infections. A ...
mRESVIA
mResvia is an RSV vaccine that may be used to protect adults aged 60 years and older against lower ...
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Rsv vaccine, mrna
Rsv vaccine, mrna systemic is used for RSV, RSV Vaccination and Immunization
References
1. (2001) "Product Information. Synagis (palivizumab)." Ross Product Division Pharmaceuticals
2. Boeckh M, Berrey MM, Bowden RA, Crawford SW, Balsley J, Corey L (2001) "Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants." J Infect Dis, 184, p. 350-4
3. Cerner Multum, Inc. "UK Summary of Product Characteristics."
4. Pharmaceutical Society of Australia (2006) APPGuide online. Australian prescription products guide online. http://www.appco.com.au/appguide/default.asp
Frequently asked questions
More about Synagis (palivizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- Drug class: antiviral monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Synagis side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.